Member Info for PCS1954

Hi Woodlands

Yep same, Barclays for me, as a previous attendee aware of procedure and have requested Letter of Representation for AGM.

That said, if you read the Notice on the website (not RNS) it clearly states you can attend with just a copy of the Notice and show it at reception, which would not confirm your holding - very bizarre!

GLA

Fascinating post krone, thanks for sharing!

GLA

The RNS for this year’s Notice of AGM doesn’t actually advise on those wishing to attend the meeting in person how to register !!!

From previous RNS’s

“Shareholders wishing to attend in person are requested to register their details info@sareum.co.uk in advance, or else bring a copy of the notice of AGM (available on the Company’s website www.sareum.com/results-reports) and present it at reception.”

Wonder who’s responsible for that little oversight, we have a COO, Company Secretary, NOMAD etc… hmmm!

GLA

* with

GLA

No one seems to have picked up on the Q&A we have gone from Toxicity Studies to Efficacy Studies - two different things which much more meaning on the latter according to my research!

GLA

Only time will tell, what I do know is by getting off my backside and going to the AGM I will at least be discussing matters with genuine shareholders, some of whom are not participants on this bb.

Off now, and not sure why the criticism of a shareholder going to an AGM!

GLA

A cup of coffee and a Sareum party bag that they give out at the Bio Convention - what do you think!

We can all bellyache and wax lyrical on a forum, I’d rather speak to people in person.

GLA

Good morning, well I’m going to the AGM!

GLA

Totally agree, witnessed first hand JR’s frustration with MHRA debacle at AGM - do wonder if TM ever gets his hands dirty these days, it’s laughable he carries the title COO!

Yes SP is a seasoned pro, that said, still think if it wasn’t for him we would have probably gone under (appreciate others may have a different opinion, that’s just mine).

AGM shouldn’t be about venting frustrations, just get this BoD to deliver a clear strategy of their self announced business model together with targeted timelines that matches the “shareholder value” they hold onto at every opportunity!

21 years and not a self orchestrated deal - time to deliver some meaningful “shareholder value” with definitive action, rather than this stumbling from one post to another!

GLA

Exactly potnak, think I could recite it word for word!

Shame you can’t make AGM!

GLA

Sorry, jumped the gun - IMC email to tell me I can view the original presentation in the “Meeting Archive” - beginning to beggar belief!!

GLA

Well surprise, surprise IMC and q&a just available!!

GLA

Ha ha Krone, think even a few of them have given up and gone !!

Anyway there has to be one red dot in the next two weeks - Notice of AGM, Annual Report etc be interested how the “difficulty” of including the warrants in the Final Results has been dealt with as alluded to by TM in the IMC presentation !!

GLA

Laz agree on the “contentious” and/or “confidential” communiques - I do think a little nudge to TM to give some update on the purpose of his 3 Bio Convention visits/was purpose achieved etc. and maybe after 3 weeks the publication of IMC q&a’s wouldn’t go amiss though - simple business manners in my book!

GLA

Hi Krone, thanks for sharing this morning - most significant point from my point of view

“For the pharmacology community, this is a particularly notable finding because it places Ang II signalling in the heart, firmly beyond its haemodynamic effects. Our intention here is not to restate their conclusions, but rather to consider how these results could be validated and translated further.”

Of course, it may be of no consequence but someone may be interested and think worthwhile in taking it further and then as potnak has alluded to potential values come into play - that’s drug development as a shareholder for you!

GLA

Agree, but just don’t think we have the funds and manpower to keep running up different avenues at this moment in time and AI/CNS seems to be the new kid on the block for JR (Toxicity Study has put the brakes on that for the moment) - a decent flip, we can “structure” hopefully the commercialisation of 1801 and 1802 and dictate the pathway of AI/CNS.

That would be my preferred option, and appreciate you and others may have a different opinion - anyway, off now good day to all.

GLA

Personally, I’d rather JR put all his time and effort in getting Toxicity Study back on track asap and SP flip 737 for whatever fair value it’s current status can bring in - you’re never going to get everything over the line, pragmatic business approach needed to get suitable funds in place and not by further dilution of Company’s shareholding!

GLA

Totally agree krone, after all, isn’t 737 our most advanced compound and therefore on paper our most “valuable” asset to attract commercialisation at this moment in time - even if flipped at a “bargain” it would put coffers in the bank and allow a more structured approach to the funding of Sareum’s other compound - yes, doors do appear to be closed, sometimes, you need to open them and look beyond.

Approx. 7 weeks to AGM, as I said I can sit that out!

GLA

Worth dyor on Singer Capital and their core business - just saying!!

Have a good afternoon, leaf collecting beckons.

GLA

My thoughts too LSBM - we can’t afford a joint broker and our current value is not encouraging to raise, but, “specialist” advice is needed in any major transaction- maybe a play for 737?

Let’s hope so🤞- ha, my sabbatical lasted a couple of days, good old Sareum 🤷🏻‍♂️

GLA